● Recruiting

Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

Condition: Obesity · Anemia · Iron Deficiencies · Sponsor: China-Japan Friendship Hospital

PhaseNA

Planned participants200

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This study aimed to explore the effects of preoperative intravenous isomaltose iron supplementation versus placebo on postoperative Hb improvement, prevention of postoperative anemia, and improvement in quality of life in patients undergoing bariatric surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Nianrong Zhang Zhang · +86 188 1048 8650 · znrsd@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

China-Japan Friendship Hospital

Beijing, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07236788